Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models.

Li, Haifu; Wozniak, Agnieszka; Sciot, Raf; Cornillie, Jasmien; Wellens, Jasmien; Van Looy, Thomas; Vanleeuw, Ulla; Stas, Marguerite; Hompes, Daphne; Debiec-Rychter, Maria; Schöffski, Patrick

Li, Haifu; Wozniak, Agnieszka; Sciot, Raf; Cornillie, Jasmien; Wellens, Jasmien; Van Looy, Thomas; Vanleeuw, Ulla; Stas, Marguerite; Hompes, Daphne; Debiec-Rychter, Maria; Schöffski, Patrick.

Afiliação

Li H; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: haifu.li@med.kuleuven.be.
Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: agnieszka.wozniak@med.kuleuven.be.
Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium. Electronic address: raf.sciot@uzleuven.be.
Cornillie J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: jasmien.cornillie@med.kuleuven.be.
Wellens J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: jasmien.wellens@med.kuleuven.be.
Van Looy T; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: thomas.vanlooy@med.kuleuven.be.
Vanleeuw U; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: ulla.vanleeuw@med.kuleuven.be.
Stas M; Department of Surgical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium. Electronic address: marguerite.stas@uz.kuleuven.ac.be.
Hompes D; Department of Surgical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium. Electronic address: daphne.hompes@uzleuven.be.
Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium. Electronic address: maria.debiec-rychter@med.kuleuve.be.
Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: patrick.schoffski@uzleuven.be.

Transl Oncol ; 7(6): 665-71, 2014 Dec.

Article em En | MEDLINE | ID: mdl-25500074

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Transl Oncol Ano de publicação: 2014 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google